Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension.

Suppr

超能文献

作者信息

Letcher R L, Chien S, Laragh J H

出版信息

J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6 Suppl):S8-20.

PMID:94641

Abstract

摘要

相似文献

Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension.

J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6 Suppl):S8-20.

[Changes in blood viscosity concomitant with prazosin therapy in patients with essential arterial hypertension].[原发性高血压患者使用哌唑嗪治疗时血液粘度的变化]

Cardiology. 1980;66 Suppl 2:12-25. doi: 10.1159/000172996.

Prazosin in severe in hypertension effect on blood pressure, plasma renin activity and in hypertensive emergencies.

Med J Aust. 1977 Aug 27;2(2 Suppl):30-2.

Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.原发性高血压治疗期间的肾灌注变化：哌唑嗪与普萘洛尔的比较

J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6 Suppl):S38-42.

Prazosin and renal hemodynamics: arteriolar vasodilation during therapy of essential hypertension in man.

J Cardiovasc Pharmacol. 1979 May-Jun;1(3):277-86.

[Hemorheologic changes in patients with essential hypertension treated with prazosin].

Med Pregl. 1992;45(7-8):285-7.

Central and renal circulation, renin and aldosterone in plasma during prazosin treatment in essential hypertension.原发性高血压患者服用哌唑嗪治疗期间的中枢与肾循环、血浆肾素及醛固酮水平

Acta Med Scand. 1979;206(6):489-94. doi: 10.1111/j.0954-6820.1979.tb13552.x.

[Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].

Cardiology. 1980;66 Suppl 2:69-73. doi: 10.1159/000173001.

Evidence of decreased plasma substance P levels in human essential hypertension and influence of prazosin treatment.原发性高血压患者血浆P物质水平降低的证据及哌唑嗪治疗的影响

Biomed Biochim Acta. 1983;42(7-8):1019-25.

[Hemodynamic changes induced with prazosin in basic conditions and during some pressor tests in essential hypertension].[哌唑嗪在原发性高血压基础状态及某些升压试验期间所引起的血流动力学变化]

Boll Soc Ital Cardiol. 1978;23(4):718-25.

引用本文的文献

Association of Whole Blood Viscosity With Metabolic Syndrome in Type 2 Diabetic Patients: Independent Association With Post-Breakfast Triglyceridemia.2型糖尿病患者全血粘度与代谢综合征的关联：与早餐后甘油三酯血症的独立关联。

J Clin Med Res. 2017 Apr;9(4):332-338. doi: 10.14740/jocmr2885w. Epub 2017 Feb 21.

A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy.外周α-1拮抗剂在高血压治疗中的不良反应综述。

Curr Control Trials Cardiovasc Med. 2002 Apr 12;3(1):7. doi: 10.1186/1468-6708-3-7.

Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.不同降压药物对高血压患者血浆纤维蛋白原的影响。

Br J Clin Pharmacol. 1995 May;39(5):471-6. doi: 10.1111/j.1365-2125.1995.tb04482.x.

Ketanserin treatment in essential hypertension.酮色林治疗原发性高血压。

Br Heart J. 1984 Sep;52(3):359-60. doi: 10.1136/hrt.52.3.359.

Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.哌唑嗪最新进展。对其药理特性以及在高血压和充血性心力衰竭治疗中的应用综述。

Drugs. 1983 Apr;25(4):339-84. doi: 10.2165/00003495-198325040-00002.

Dose-titration study of alfuzosin, a new alpha 1-adrenoceptor blocker, in essential hypertension.

Eur J Clin Pharmacol. 1988;35(1):25-30. doi: 10.1007/BF00555503.

Effect of diet and weight loss on whole blood filterability and plasma fibrinogen values in hypertensive obese postmenopausal women.饮食和体重减轻对高血压肥胖绝经后妇女全血过滤性和血浆纤维蛋白原值的影响。

Acta Diabetol Lat. 1989 Oct-Dec;26(4):329-35. doi: 10.1007/BF02624645.

Flow resistance and its components in hypertensive men treated with the calcium antagonist isradipine.接受钙拮抗剂伊拉地平治疗的高血压男性的血流阻力及其组成部分。

Eur J Clin Pharmacol. 1992;43(5):463-8. doi: 10.1007/BF02285086.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验